SNSE Sensei Biotherapeutics
- 0.970
- -0.013-1.31%
Sensei Biotherapeutics News
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Newtyn Management, LLC(4.95%),Newtyn Capital Partners, LP(4.95%), etc.
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Sensei Biotherapeutics | 10-K: Annual report
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer van der Horst Edward
Sensei Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Celebi John
Sensei Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Colgan Erin
Sensei Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Newtyn Management, LLC(5.83%),Newtyn Capital Partners, LP(5.83%), etc.
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics: Q3 2023 Earnings Report
Sensei Biotherapeutics | 8-K: Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Newtyn Management, LLC(6.5%),Newtyn Capital Partners, LP(6.5%), etc.
Sensei Biotherapeutics | 8-K: Current report
Sensei Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Krebs Stephanie
Sensei Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Officer Krebs Stephanie
Analysis
Price Target
No Data
